Odyssey Therapeutics
Odyssey Therapeutics went public on May 7, 2026. This company is no longer tradable on Hiive.
$20.00
IPO price
$16.50
Day 1 closing price
High-growth private companies trade on Hiive before they go public. Sign up to explore the market.
Sign upOdyssey Therapeutics completed its IPO on May 7, 2026, listing with the ticker ODTX. Odyssey Therapeutics is no longer tradable on Hiive.
If you have any questions about buying or selling shares of private companies, don't hesitate to contact us at [email protected].
Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.
Date
September 2025 (Series D)
Capital Raised
$213m of $716.22b total
Industries
Health Care
Biotechnology
Therapeutics
High-growth private companies trade on Hiive before they go public. Sign up to explore the market.
Sign upOdyssey Therapeutics completed its IPO on May 7, 2026, listing with the ticker ODTX. Odyssey Therapeutics is no longer tradable on Hiive.
If you have any questions about buying or selling shares of private companies, don't hesitate to contact us at [email protected].
Odyssey Therapeutics is a publicly traded company under the stock ticker ODTX. To invest, you must open a brokerage account with a platform that allows you to buy U.S. stocks, such as Robinhood, Vanguard, Fidelity, or your bank's brokerage division. Once your account is funded, search for ODTX stock and place a buy order.
Since Odyssey Therapeutics has gone public via IPO (initial public offering), SPAC, or direct listing, its shares are available to all individual investors in the public market. You can purchase shares using the Odyssey Therapeutics stock ticker symbol ODTX through any standard brokerage account.
You can freely sell Odyssey Therapeutics stock after its IPO (initial public offering), SPAC, or direct listing, provided you purchased the shares on the open market through your brokerage account. Certain early investors, employees, and company executives are often subject to a lock-up period after the company trades publicly which restricts them from selling their shares for a set time — typically 90 to 180 days. Once that lock-up period expires, those shareholders will also be able to sell their Odyssey Therapeutics shares without restriction.
To find the current stock price for Odyssey Therapeutics, you first need its stock ticker symbol. You can find this information by searching the company name on major financial websites or by checking the investor relations section of the company's official website. Once you have the ticker ODTX for Odyssey Therapeutics, enter it into any brokerage account platform or reputable financial news site to see its real-time share price.
Odyssey Therapeutics' valuation is primarily measured by its market capitalization, which constantly changes with its stock price. This figure is calculated by multiplying the live share price by the total number of outstanding shares, reflecting its public market value. Investors also look at metrics like the enterprise value and price-to-sales ratio to assess the premium the market places on Odyssey Therapeutics.
Yes, Odyssey Therapeutics is publicly traded and its stock is available for purchase by the general public. The company completed its IPO (initial public offering), SPAC, or direct listing, and its shares are now listed publicly. Investors can find and trade the shares under the stock ODTX through any standard brokerage account.
Trade private stock now.
The marketplace for private stock
Securities are offered by Hiive Markets Limited, member of FINRA / SIPC and registered exempt market dealer in Ontario, British Columbia, Alberta, Saskatchewan, Manitoba and Nova Scotia. Brokerage fees may apply. Find Hiive on BrokerCheck. Hiive does not conduct or solicit brokerage activities in any jurisdiction where it is not registered or otherwise authorized to do so.
The information on this website is provided “as-is”. Investing in private securities is speculative, illiquid, and involves the risk of loss. Pre-IPO companies are privately owned; not all private companies will experience an IPO or other liquidity event. Hiive does not provide investment advice and Hiive customers should obtain independent advice prior to buying or selling on Hiive. References to securities do not constitute an offer by Hiive to buy or sell, or a solicitation of an offer, nor a recommendation, to buy or sell, any security. Hiive is not affiliated or associated with, or endorsed by, any of the companies mentioned herein. All services or trademarks are the property of their respective owners.
© The Hiive Company Limited 2026. All rights reserved. By using this site, you accept our Terms of Use, Security and Privacy Policy. Before engaging with this broker-dealer, review these important Disclosures and the Form CRS (US) and Relationship Disclosure (Canada).